Literature DB >> 21524574

Synthesis and evaluation of indole-based new scaffolds for antimicrobial activities--identification of promising candidates.

Palwinder Singh1, Pooja Verma, Puja Verma, Bhawna Yadav, Sneha S Komath.   

Abstract

Search for new antimicrobial agents led to the synthesis of series of N-1, C-3 and C-5 substituted bis-indoles. Their evaluation for antifungal and antibacterial activities resulted in the optimization of pyrrolidine/morpholine/N-benzyl moiety at the C-3 end and propane/butane/xylidine groups as linkers between two indoles for significant inhibition of microbial growth. Preliminary investigations have identified three highly potent antimicrobial agents. Dockings of these molecules in the active sites of lanosterol demethylase, dihydrofolate reductase and topoisomerase II indicate their strong interactions with these enzymes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524574     DOI: 10.1016/j.bmcl.2011.04.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities.

Authors:  Mukund P Tantak; Jing Wang; Rajnish Prakash Singh; Anil Kumar; Kavita Shah; Dalip Kumar
Journal:  Bioorg Med Chem Lett       Date:  2015-08-06       Impact factor: 2.823

2.  Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities.

Authors:  Mukund P Tantak; Vishakha Gupta; Kumar Nikhil; V Arun; Rajnish Prakash Singh; Prabhat Nath Jha; Kavita Shah; Dalip Kumar
Journal:  Bioorg Med Chem Lett       Date:  2016-04-28       Impact factor: 2.823

3.  Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.

Authors:  Chi Liu; Gu He; Qinglin Jiang; Bo Han; Cheng Peng
Journal:  Int J Mol Sci       Date:  2013-07-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.